The tight-binding nonnucleoside reverse transcriptase inhibitor (NNRTI) UC781is under development as a topical microbicide to prevent sexual transmission of the human immunodeficiency virus type 1 (HIV-1). However, there are concerns whether UC781 will be broadly effective against different HIV subtypes as well as against the increasingly prevalent NNRTI-resistant HIV strains....